Smart dosing for Crohn's: computer program aims to improve treatment
NCT ID NCT04974099
First seen Apr 28, 2026 · Last updated Apr 28, 2026
Summary
This study tested whether a computer program could help doctors give the right dose of infliximab to children and young adults with Crohn's disease. The goal was to see if personalized dosing based on blood tests could achieve better drug levels than standard dosing. The study was terminated early, but it aimed to gather safety data and see if the approach was feasible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cincinnati Children's Hospital
Cincinnati, Ohio, 45229, United States
Conditions
Explore the condition pages connected to this study.